View Mobile No.

our range

Sofosbuvir And Velpatasvir Tablets

Our product range includes a wide range of resof total, velpanat tablets, myhep all tablets ( sofosbuvir 400mg & velpatasvir 100mg tablets - mylan), qurled - v tablets sofosbuvir 400mg & velpatasvir 100mg, hepcvel tablets sofosbuvir 400mg & velpatasvir 100mg and velasof tablets (sofosbuvir 400mg and velpatasvir 100mg ).
Resof Total

Resof Total

Rs 9,500  / BottleGet Best Price

Minimum Order Quantity: 1 Bottle

Strength400mg & 100mg
ManufacturerDr.Reddy's Laboratories Ltd
CompositionSofosbuvir 400mg & Velpatasvir 100mg
TreatmentHepatitis C virus Infection (HCV)
Prescription/Non prescriptionPrescription
Usage/ApplicationHepatitis C virus Infection (HCV)
Brand NameResof Total
Dosage FormTablet
Dose/Strength (e.g. 1 mg )400 mg & 100 mg
BrandResof
Packaging Size28 Tablets
We are manfacturer,trader & supplier of    Resof Total.
Resof Total is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

Additional Information:

  • Production Capacity: Large
  • Delivery Time: Immediate
  • Packaging Details: 28 Tablets in a bottle

View Complete details

get quoterequest a call back
  • Velpanat Tablets
  • Velpanat Tablets
Velpanat Tablets

Velpanat Tablets

Rs 10,990  / BottleGet Best Price

Minimum Order Quantity: 1 Bottle

StrengthSofosbuvir 400mg & Velpatasvir 100mg
Dosage FormTablet
TreatmentHepatitis C virus infection (HCV)
CompositionSofosbuvir & velpatasvir
Drug NameVelpanat
Prescription/Non prescriptionPrescription
Packaging Size28 Tablets
Packaging TypeBottle
ManufacturerNatco Pharma Ltd
Active IngredientSofosbuvir & Velpatasvir
FormTablet
UsesHep C
Dose/Strength (ex. 1 mg or 1 ml)100 mg/400 mg
UsageHospital, Clinical
IndicationsHep C
Dose/Strength400mg & 100mg
Manufactured ByNatco
Marketed ByNatco
BrandVelpanat

We are manfacturer,trader & supplier of  Velpanat tablet. Velpanat is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. Velpanat is the FDA approved product, which is used in chronic HCV condition. Velpanat should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections.

DOSAGE BEFORE THE TREATMENT

Examine the patients thoroughly, before initiating the treatment with HCV anti-viral agents. Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs. Velpanat tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of Velpanat; The usual recommended dose of Velpanat is, one tablet should be administered orally as a single dose. Velpanat tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir

WORKS

 

Sofosbuvir is a NS5B protein inhibitor, protein is essential for viral production. Sofosbuvir is a prodrug form, which get converted into active uridine triphosphate form which is required for anti-viral activity. This dynamic active moiety is get inserted into HCV RNA with the help of NS5B polymerase and leads as chain eliminator. Velpatasvir is pharmacologically acts as NS5A inhibitor; this protein is required for HCV viral production. Velpatasvir is involved its action in viral production process.
UNFAVORABLE EFFECTS 

Serious bradycardia occurs due to concomitant use of Velpanat with amiodarone. Insomnia Irritability Headache Fatigue Nausea Asthenia

LAB ABNORMALITIES

Lipase elevation Elevation of creatine kinase Elevation of bilirubin levels

POST MARKETING EFFECTS

Cardiac disorders Rashes Angioedema

Velpanat Tablet Manufactured & Marketed By Natco Pharma Ltd



Additional Information:

  • Production Capacity: Large
  • Delivery Time: Immediate
  • Packaging Details: 1x28 Tablets in a bottle

View Complete details

get quoterequest a call back
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
  • Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)
Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)

Myhep All Tablets ( Sofosbuvir 400mg & Velpatasvir 100mg Tablets - Mylan)

Rs 9,500  / UnitGet Best Price

Minimum Order Quantity: 1 Unit

Dosage FormTablet
BrandMyhep all
CompositionSofosbuvir & Velpatasvir
FormTablets
Drug NameSofosbuvir 400mg and Velpatasvir 100mg
Packaging Size28 Tabs per bottle
Packaging TypeBottle
Brand NameMyhep All
Dosageas per doctor advice
Usage/ApplicationHepatitis C Virus ( HCV )
IndicationsHepatitis C Virus ( HCV )
Dose/Strength400mg & 100mg
Type Of MedicinesAllopathic

We are manfacturer,trader & supplier of  Myhep-All tablets.

Myhep-All is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. Myhep-All is the FDA approved product, which is used in chronic HCV condition. Myhep-All should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections.

 

 

DOSAGE BEFORE THE TREATMENT

Examine the patients thoroughly, before initiating the treatment with HCV anti-viral agents. Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs. Myhep-All tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of Myhep-All; The usual recommended dose of Myhep-All is, one tablet should be administered orally as a single dose. Myhep-All tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir

 

mechanism of actions

Sofosbuvir is a NS5B protein inhibitor, protein is essential for viral production. Sofosbuvir is a prodrug form, which get converted into active uridine triphosphate form which is required for anti-viral activity. This dynamic active moiety is get inserted into HCV RNA with the help of NS5B polymerase and leads as chain eliminator. Velpatasvir is pharmacologically acts as NS5A inhibitor; this protein is required for HCV viral production. Velpatasvir is involved its action in viral production process

 

Dosage and Administration

 

Patients suffered with compensated cirrhosis or without cirrhosis; One tablet of Myhep-All should be administered orally as once daily over period of 12 weeks. Patients suffered with decompensated cirrhosis; One Myhep-All tablet should be combined with weight based ribavirin by administering with food for 12 hours. The dose of ribavirin should be calculated for the patients; Patient with <75kg of body weight, the recommended dose of ribavirin is 1000mg administered as twice daily. Patient with at least 75kg of body weight, recommended dose of ribavirin is 1200mg administered as twice daily. For both renal & hepatic impaired patients; Myhep-All tablets dosage adjustment should not be recommended.

PHARMACOKINETICS

The maximum plasma concentration of Myhep-All is;
Sofosbuvir at 0.5 to 1 hour & Velpatasvir at 3 hours Food does not affect the absorption of Myhep-All The Myhep-All tablet is highly bound to human plasma protein is; Sofosbuvir 61 to 65% & Velpatasvir by >99.5%
The blood plasma ratio of;
Sofosbuvir 0.7 & Velpatasvir 0.52 to 0.67. The Myhep-All metabolism is majorly occurs in liver; sofosbuvir by cathepsin A or carboxyl esterase 1 & Velpatasvir by CYP2B6, CYP2C8 or CYP3A4.
Myhep-All excretion occurs via;
Sofosbuvir by urine (80%), feces (14%) & exhaled air (2.5%) & Velpatasvir by urine (88%) & feces (6.6%) The half lives of Myhep-All;
UNFAVORABLE EFFECTS 

Serious bradycardia occurs due to concomitant use of Myhep All with amiodarone. Insomnia Irritability Headache Fatigue Nausea Asthenia

LAB ABNORMALITIES

Lipase elevation Elevation of creatine kinase Elevation of bilirubin levels

POST MARKETING EFFECTS

Myhep all is manufactured and marketed by Mylan ltd

 



Additional Information:

  • Production Capacity: large
  • Packaging Details: 1 x 28 tabs in a bottle

View Complete details

get quoterequest a call back
Qurled - V Tablets Sofosbuvir 400mg & Velpatasvir 100mg

Qurled - V Tablets Sofosbuvir 400mg & Velpatasvir 100mg

Rs 9,250  / BottleGet Best Price

Minimum Order Quantity: 1 Bottle

Packaging Size1x28
Strength400mg/100mg
CompositionSofosbuvir 400mg & Velpatasvir 100mg
TreatmentHepatitis C virus infection (HCV)
Prescription/Non prescriptionPrescription
BrandQurled -VStrides
ManufacturerStrides Shasun Ltd
FormTablet
Shelf life2 years
Therapeutic UsesHepatitis C virus infection (HCV)
We are manfacturer,trader & supplier of Qurled-V tablet. Qurled-V tablet contains Sofosbuvir 400mg & Velpatasvir 100mg is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. Qurled-V is the FDA approved product, which is used in chronic HCV condition. Qurled-V should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections.
DOSAGE BEFORE THE TREATMENT

Examine the patients thoroughly, before initiating the treatment with HCV anti-viral agents. Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs. Qurled-V tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of Qurled-V; The usual recommended dose of Qurled-V is, one tablet should be administered orally as a single dose. Qurled-V tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir

WORKS

 

Sofosbuvir is a NS5B protein inhibitor, protein is essential for viral production. Sofosbuvir is a prodrug form, which get converted into active uridine triphosphate form which is required for anti-viral activity. This dynamic active moiety is get inserted into HCV RNA with the help of NS5B polymerase and leads as chain eliminator. Velpatasvir is pharmacologically acts as NS5A inhibitor; this protein is required for HCV viral production. Velpatasvir is involved its action in viral production process.\

WORKS

 

Sofosbuvir is a NS5B protein inhibitor, protein is essential for viral production. Sofosbuvir is a prodrug form, which get converted into active uridine triphosphate form which is required for anti-viral activity. This dynamic active moiety is get inserted into HCV RNA with the help of NS5B polymerase and leads as chain eliminator. Velpatasvir is pharmacologically acts as NS5A inhibitor; this protein is required for HCV viral production. Velpatasvir is involved its action in viral production process.
Qurled-V UNFAVORABLE EFFECTS 

Serious bradycardia occurs due to concomitant use of  
Qurled-V  with amiodarone. Insomnia Irritability Headache Fatigue Nausea Asthenia

LAB ABNORMALITIES 

Lipase elevation Elevation of creatine kinase Elevation of bilirubin levels

POST MARKETING EFFECTS

Cardiac disorders Rashes Angioedema



Additional Information:

  • Production Capacity: Large
  • Delivery Time: Immediate
  • Packaging Details: 28 Tablets in a bottle

View Complete details

get quoterequest a call back
Hepcvel Tablets Sofosbuvir 400mg & Velpatasvir 100mg

Hepcvel Tablets Sofosbuvir 400mg & Velpatasvir 100mg

Rs 9,500  / BottleGet Best Price

Minimum Order Quantity: 1 Bottle

Packaging Size1x28
Strength400mg/100mg
CompositionSofosbuvir 400mg & Velpatasvir 100mg
TreatmentHepatitis C virus infection (HCV)
Prescription/Non prescriptionPrescription
BrandHepcvel-Cipla
ManufacturerCipla Ltd
FormTablet
Shelf life2 years
Therapeutic UsesHepatitis C virus infection (HCV)
We are manfacturer,trader & supplier of Hepcvel Tablets. Hepcvel is Sofosbuvir 400mg & Velpatasvir 100mg is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. Hepcvel is the FDA approved product, which is used in chronic HCV condition. Hepcvel should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections.
DOSAGE BEFORE THE TREATMENT

Examine the patients thoroughly, before initiating the treatment with HCV anti-viral agents. Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs. Hepcvel tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of Hepcvel; The usual recommended dose of Hepcvel is, one tablet should be administered orally as a single dose. Hepcvel tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir
UNFAVORABLE EFFECTS

Serious bradycardia occurs due to concomitant use of Hepcvel with amiodarone. Insomnia Irritability Headache Fatigue Nausea Asthenia



Additional Information:

  • Production Capacity: Large
  • Delivery Time: Immediate
  • Packaging Details: 28 Tablets in a Bottle

View Complete details

get quoterequest a call back
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
  • Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )
Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )

Velasof Tablets (Sofosbuvir 400mg And Velpatasvir 100mg )

Rs 8,500  / UnitGet Best Price

Minimum Order Quantity: 1 Unit

BrandVelasof
Dosage FormTablet
CompositionSofosbuvir & Velpatasvir
FormTablet
Drug NameVelasof
Prescription/Non prescriptionPrescription
Usage/ApplicationHospital
Packaging Size28 Tablets
Brand NameVelasof
DosageSofosbuvir 400mg + Velpatasvir 100mg
Active IngredientSofosbuvir & Velpatasvir
ManufacturerHetero Health Care Limited
Packaging Type28 Tablets In a Bottle
UsesHCV Infection ( Hepatitis C )
Dose/Strength400 Mg & 100 Mg
Manufactured ByHetero Healthcare Ltd
Marketed ByHetero Healthcare Ltd
ApplicationHCV Infection ( Hepatitis C )

We are manufacturer,trader & supplier of Velasof Tablets.
Velasof Tablets  contains Sofosbuvir 400mg and Velpatasvir 100mg used to treat HCV infections ( Hepatitis C)

How Velasof Tablet works

Velasof Tablet is a combination of two antiviral medicines: Sofosbuvir and Velpatasvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.

How to use Velasof Tablet

 Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Velasof Tablet may be taken with or without food, but it is better to take it at a fixed time.

Velasof is manufactured and marketed by Hetero Healthcare Ltd



Additional Information:

  • Production Capacity: Large
  • Delivery Time: Immediate
  • Packaging Details: 1 x 28 tabs in a bottle

View Complete details

get quoterequest a call back

EXPLORE MORE CATEGORIES